Laurion Capital Management LP Exelixis, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$20.34 - $23.73 $272,088 - $317,436
13,377 New
13,377 $300,000
Q3 2020

Nov 13, 2020
SELL
$20.67 - $26.94 $909,480 - $1.19 Million
-44,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$16.46 - $27.42 $551,163 - $918,158
33,485 Added 318.45%
44,000 $1.05 Million
Q3 2017

Nov 13, 2017
BUY
$23.35 - $29.24 $245,525 - $307,458
10,515
10,515 $255,000

Others Institutions Holding EXEL

# of Institutions
501
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email